Background Obesity is an important risk factor for Barrett adenocarcinoma. However, the
role of adiponectin (anti-inflammatory adipokine from adipose tissue) and ghrelin …

Background Deoxycholic acid (DCA) promotes the development and progression of
esophageal adenocarcinoma (EAC) by inducing inflammation. Adiponectin is reported to …

Obesity increases the risk of developing several cancers including oesophageal
adenocarcinoma (OAC). Obesity is characterised by hyperleptinaemia and …

Background Adiponectin is inversely related to BMI, positively correlates with insulin
sensitivity, and has anti-atherogenic effects. In recent years, adiponectin has been well …

The incidence of oesophageal adenocarcinoma has increased dramatically in the
developed world in the last half century. Over approximately the same period there has been …

BACKGROUND & AIMS: Epidemiological studies have shown that obesity is a risk factor for
hepatocellular carcinoma (HCC). Lower adiponectin levels are associated with poor …

Purpose Adipocytokines are adipocyte-secreted hormones associated with some
malignancies. We investigated the association of adipocytokines with gastric cancer …

Background: Recently, increased body weight has been associated with an increased risk of
cancers at multiple specific sites, including gastric cancer. Adiponectin is a peptide hormone …

Background Obesity is associated with oesophageal adenocarcinoma, but mechanisms
linking fat and carcinogenesis remain poorly understood. Altered circulating adipocytokines …

Adiponectin is known to have suppressive effects on tumor growth and is thought to be a key
molecule in the positive correlation between obesity and cancer. However, the detailed …